The paradigm shift in ANCA-associated vasculitis: prime time for the complement targeting

Affiliations

¹ Division of Rheumatology, Department of Medicine, University of Udine, Udine, Italy.
² Nephrology Unit, University of Brescia, Azienda Socio Sanitaria Territoriale Spedali Civili, Brescia, Italy.

Comment

Luca Quartuccio et al. Rheumatology (Oxford). 2023.

. 2023 Aug 1;62(8):2633-2634.

doi: 10.1093/rheumatology/kead188.

¹ Division of Rheumatology, Department of Medicine, University of Udine, Udine, Italy.
² Nephrology Unit, University of Brescia, Azienda Socio Sanitaria Territoriale Spedali Civili, Brescia, Italy.

No abstract available

Comment on

CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum.
Turgeon D, Bakowsky V, Baldwin C, Cabral DA, Clements-Baker M, Clifford A, Cohen Tervaert JW, Dehghan N, Ennis D, Famorca L, Fifi-Mah A, Girard LP, Lefebvre F, Liang P, Makhzoum JP, Massicotte-Azarniouch D, Mendel A, Milman N, Reich HN, Robinson DB, Ross C, Rumsey DG, Soowamber M, Towheed TE, Trudeau J, Twilt M, Yacyshyn E, Yardimci GK, Khalidi N, Barra L, Pagnoux C. Turgeon D, et al. Rheumatology (Oxford). 2023 Aug 1;62(8):2646-2651. doi: 10.1093/rheumatology/kead087. Rheumatology (Oxford). 2023. PMID: 36805625